These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25451949)

  • 1. Implications of reverse cholesterol transport: recent studies.
    Levinson SS; Wagner SG
    Clin Chim Acta; 2015 Jan; 439():154-61. PubMed ID: 25451949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL-cholesterol and cardiovascular disease: rethinking our approach.
    Siddiqi HK; Kiss D; Rader D
    Curr Opin Cardiol; 2015 Sep; 30(5):536-42. PubMed ID: 26192490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y13 receptor is critical for reverse cholesterol transport.
    Fabre AC; Malaval C; Ben Addi A; Verdier C; Pons V; Serhan N; Lichtenstein L; Combes G; Huby T; Briand F; Collet X; Nijstad N; Tietge UJ; Robaye B; Perret B; Boeynaems JM; Martinez LO
    Hepatology; 2010 Oct; 52(4):1477-83. PubMed ID: 20830789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for low high-density lipoproteins.
    Hafiane A; Kellett S; Genest J
    Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):134-9. PubMed ID: 24535232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse cholesterol transport and atherosclerosis. A mini review.
    Cucuianu M; Coca M; Hâncu N
    Rom J Intern Med; 2007; 45(1):17-27. PubMed ID: 17966439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis.
    Ganjali S; Watts GF; Banach M; Reiner Ž; Nachtigal P; Sahebkar A
    Curr Med Chem; 2021; 28(29):6066-6081. PubMed ID: 33563147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention.
    Sirtori CR
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1543-54. PubMed ID: 21961529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
    Tuteja S; Rader DJ
    Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoproteins, reverse cholesterol transport and atherogenesis.
    Pownall HJ; Rosales C; Gillard BK; Gotto AM
    Nat Rev Cardiol; 2021 Oct; 18(10):712-723. PubMed ID: 33833449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebeta-1 HDL and coronary heart disease.
    Kane JP; Malloy MJ
    Curr Opin Lipidol; 2012 Aug; 23(4):367-71. PubMed ID: 22517613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of reverse cholesterol transport.
    Tall AR
    Eur Heart J; 1998 Feb; 19 Suppl A():A31-5. PubMed ID: 9519340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux and reverse cholesterol transport.
    Favari E; Chroni A; Tietge UJ; Zanotti I; Escolà-Gil JC; Bernini F
    Handb Exp Pharmacol; 2015; 224():181-206. PubMed ID: 25522988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HDL and reverse cholesterol transport. Role of cholesterol ester transfer protein].
    Lagrost L; Gambert P
    C R Seances Soc Biol Fil; 1992; 186(4):405-13. PubMed ID: 1301229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo.
    Nakaya K; Ayaori M; Uto-Kondo H; Hisada T; Ogura M; Yakushiji E; Takiguchi S; Terao Y; Ozasa H; Sasaki M; Komatsu T; Ohsuzu F; Ikewaki K
    Atherosclerosis; 2010 Nov; 213(1):135-41. PubMed ID: 20723893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of drugs on high-density lipoprotein.
    McKenney JM
    J Clin Lipidol; 2007 Mar; 1(1):74-87. PubMed ID: 21291670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse cholesterol transport fluxes.
    Hellerstein M; Turner S
    Curr Opin Lipidol; 2014 Feb; 25(1):40-7. PubMed ID: 24362356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.